Table 3.
Incremental cost-effectiveness results using NNT
| Guided iCBT | Self-managed iCBT | |
|---|---|---|
| Significant reduction on the FACT-ESa | ||
| Number needed to treat (NNT) | 4.74 | 6.06 |
| Incremental intervention costs | € 226.09 | € 47.92 |
| Incremental total costs (total healthcare) | € 321.65 | € 124.32 |
| Total incremental costs to treat one patient (intervention perspective) | € 1071.51 | € 290.39 |
| Total incremental costs to treat one patient (healthcare perspective) | € 1524.62 | € 753.38 |
| Significant reduction on the HFRS problem rating scalea | ||
| Number needed to treat (NNT) | 4.54 | 4.02 |
| Incremental intervention costs | € 226.09 | € 47.92 |
| Incremental total costs (total healthcare) | € 321.65 | €124.32 |
| Total incremental costs to treat one patient (intervention perspective) | € 1026.45 | € 192.64 |
| Total incremental costs to treat one patient (healthcare perspective) | € 1460.29 | € 499.77 |
NNT number needed to treat, FACT-ES functional assessment of cancer treatment-endocrine symptoms, HFRS hot flush rating scale
aWaiting list control group is reference category